Cookson Peirce & Co’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
14,797
+800
+6% +$64.5K 0.04% 197
2026
Q1
$990K Buy
13,997
+3,196
+30% +$239K 0.04% 187
2025
Q4
$853K Buy
+10,801
New +$855K 0.04% 203
2023
Q1
Sell
-332,672
Closed -$24.1M 241
2022
Q4
$24.1M Buy
332,672
+2,056
+0.6% +$147K 1.57% 23
2022
Q3
$20.1M Buy
330,616
+2,699
+0.8% +$172K 1.42% 26
2022
Q2
$20.6M Buy
327,917
+12,007
+4% +$795K 1.42% 26
2022
Q1
$22.2M Buy
315,910
+17,816
+6% +$1.2M 1.3% 31
2021
Q4
$18.6M Buy
298,094
+13,654
+5% +$857K 1.04% 35
2021
Q3
$17.6M Buy
284,440
+1,914
+0.7% +$115K 1.07% 29
2021
Q2
$16.9M Buy
+282,526
New +$17.9M 1.05% 31

Other funds holding MET

Cookson Peirce & Co's MET Position: Q2 2026 in Review

Cookson Peirce & Co increased its MetLife (MET) stake by 5.7% in Q2 2026, buying an estimated $64.5K and bringing the position to 14,797 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #197.

Cookson Peirce & Co first reported a position in MET in Q2 2021 and has held it in 10 quarters since. The position peaked at $24.1M in Q4 2022. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Cookson Peirce & Co held 14,797 shares of MetLife worth $1.25M as of Q2 2026.
  • Cookson Peirce & Co bought 800 MetLife shares in Q2 2026, an estimated $64.5K.
  • MetLife made up 0.04% of Cookson Peirce & Co's portfolio in Q2 2026, its #197 holding.
  • Cookson Peirce & Co first reported a position in MetLife in Q2 2021 and has held it in 10 quarters since.
  • Cookson Peirce & Co's MetLife position peaked at $24.1M in Q4 2022.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.